Attractnet
1 paper1 finding
- 1 lab in 1 country
- Human trial1
Associations
1Transthyretin amyloid cardiomyopathy
upin humans1
1 study
Transthyretin amyloid cardiomyopathy
upin humans1
Attractnet predicts transthyretin amyloid cardiomyopathy in humans (AUC 0.85).
“It had good discrimination for ATTR-CM detection with an area under the receiver operator characteristic curve of 0.85 (5-fold cross-validation, 0.77-0.85) in the internal set”
Human trialinternal test set
JAMA cardiology10 Nov 2025
Latest
1 in 12 monthsJAMA Cardiology
Detecting Transthyretin Cardiac Amyloidosis With Artificial Intelligence: A Nonrandomized Clinical Trial
Non-randomised trial in 799 peopleBiomarkers